Abstract
By means of positron emission tomography the uptake and kinetics of N-(methyl-11C)clozapine in different brain regions have been studied in Rhesus monkeys. 11C-clozapine rapidly entered the brain and maximum radioactive uptake was seen 5–12 min after administration. Highest uptake was measured in the striatum. Other regions with an uptake higher than in the cerebellum were thalamus and mesencephalon. The radioactivity from different brain regions decreased with an elimination half-life of about 5 h and parallelled the plasma kinetics of unlabelled clozapine. The striatum/cerebellum ratio of 11C-clozapine-derived radioactivity remained constant during the period studied and did not change after pretreatment with atropine. In contrast, the striatum/cerebellum ratio was somewhat lower after pretreatment with N-methylspiperone (NMSP), indicating competition for the same binding sites in the striatum. After pretreatment with increasing doses of clozapine, a dose-dependent protection of binding sites in the striatum for 11C-NMSP was seen. It is concluded that clozapine is more loosely bound to dopamine receptors in the striatum than N-methylspiperone and that the kinetics of clozapine in the brain parallel that in the plasma. The binding properties of clozapine within the brain may explain some of the clinical properties of the drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén N-E, Stock G (1973) Effect of clozapin on the turnover of dopamine in the corpus striatum and in the limbic system. J Pharm Pharmacol 25:346–348
Burns DH, Dannals RF, Långström B, Ravert HT, Zemyan SE, Duelfer T, Wong D, Frost JJ, Kuhar MJ, Wagner HN Jr. (1984) N-(11C-methyl) spiperone, a ligand binding to dopamine receptors; radiochemical synthesis and biodistribution studies in mice. J Nucl Med 25:1222–1227
Carlsson A, Lindqvist M (1963) Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrin in mouse brain. Acta Pharmacol Toxicol 20:140–144
Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481–483
Eckernäs SÅ, Aquilonius SM, Bergström K, Hartvig P, Lilja A, Lindberg B, Lundqvist H, Långström B, Malmborg L, Moström M, Någren K (1983) The use of positron emission tomography for the examination of choline metabolism in the brain of Rhesus monkey. In: Honin A (ed) Dynamics of cholinergic function. Advances in Behavioral Biology. Raven Press, New York
Ehrin E, Farde L, dePaulis T, Eriksson L, Greitz T, Jonström P, Litton JE, Nilsson L, Sedvall G, Stone-Elander S, Ögren SO (1985) Preparation of 11C-labelled raclopride, a new dopamine receptor antagonist. Preliminary positron emission tomographic study of cerebro-dopamine-receptors in the monkey. Int J Appl Radiat Isotope (in press)
Ekblom B, Häggström J-E (1974) Clozapine (Leponex®) compared with chlorpromazine. A double-blind evaluation of pharmacological and clinical properties. Curr Ther Res 16:945–957
Ekblom B, Eriksson K, Lindström LH (1984) Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology 83:293–294
Eriksson L, Bohm C, Kesselberg M, Blomquist G, Litton J, Widen L, Bergström M, Eriksson K, Greitz T (1982) A four ring positron camera system for emission tomography of the brain. IEEE Trans Nuclear Sci 29:539–543
Fjalland B, Christensen AV, Hyttel J (1977) Peripheral and central muscarinic receptor affinity of psychotropic drugs. Naunyn-Schmiedeberg's Arch Pharmacol 301:5–12
Frost J, Dannals R, Ravert H, Wilson A, Links J, Trifiletti R, Snyder S, Wagner H (1985) Imaging benzodiazepine receptors in man with C-11-suriclone and positron emission tomography. Society of Nuclear Medicine 32nd Annual Meeting Houston, Texas, June 1985
Gerlach J, Koppelhus P, Helweg E, Monrad A (1974) Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr Scand 50:410–424
Hartvig P, Bergström K, Lindberg B, Lundberg PO, Lundqvist H, Långström B, Svärd H, Rane A (1984) Kinetics of 11C-labeled opiates in the brain of Rhesus monkeys. J Pharmacol Exp Ther 230:250–255
Långström B, Antoni G, Halldin C, Svärd H, Bergson G (1982) Synthesis of some 11C-labelled alkaloids. Chemica Scripta 20:46–48
Långström B, Antoni G, Halldin C, Svärd H, Bergson G (1984) 11C-Methyl-iodide in N-Alkylation reactions of 11C-labelled radiopharmaceuticals. J Label Comp Radiopharmaceut 21:1200–1202
Maziere M, Prenant Ch, Sastre J, Crouzel M, Comar D, Hautraye D, Kaisima M, Guibert B, Naquet R (1983) Ro 15-1788-11C and flunitrazepam-11C; two code notes for the study of benzodiazepine binding sites by positron emission tomography. Acad Sci Paris 3:871–874
Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137:1518–1522
Povlsen UJ, Noring U, Fog R, Gerlach J (1985) Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years. Acta Psychiatr Scand 71:176–185
Randrup A, Munkvad I (1972) Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain. Orthomolec Psychiatry 1:2–7
Richelson E (1980) Neuroleptics and neurotransmitter receptors. Psychiatr Ann 10:21–26
Sayers A, Burki H, Ruch W, Asper H (1975) Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesia. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia 41:97–104
Seeger TF, Gardner EL (1979) Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: evidence for mesolimbic supersensitivity. Brain Res 1975:49–56
Wagner H, Burns D, Dannals R, Wong D, Långström B, Duelfer T, Frost J, Ravert H, Links JM, Rosenblom SB, Lukas S, Kramer A, Kuhar M (1984) Imagin dopamine receptors in the human brain by Positron Tomography. Science 221:1264–1266
Wong D, Wagner H, Dannals R, Links J, Frost J, Ravert H, Wilson A, Rosenbaum A, Folstein M, Petronis J, Douglass K, Toung T, Kuhar M (1984) Effects on age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226:1393–1396
Wong DF, Wagner H, Coyle J, Snyder S, Dannals R, LaFrance N, Bice A, Pearlson G, Links J, Paulos M, Hoehn-Saric R, Tune L, Kuhar M (1985a) Assessment of dopamine receptor blockade by neuroleptic drugs in the living human brain. Society of Nuclear Medicine 32nd Annual Meeting, Houston, Texas, June 1985
Wong D, Tune L, Wagner Jr, H, Suneja S, Bjorvinsson E, Pearlson G, Dannals R, Ravert H, Wilson A, Links J, Schaerf F, Kuhar M (1985b) In vivo assessment of dopamine and serotonin receptors measured by C-11-N-methylspiperone (NMSP) in patients with schizophrenia. Society of Nuclear Medicine 32nd Annual Meeting, Houston, Texas, June 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hartvig, P., Eckernäs, S., Lindström, L. et al. Receptor binding of N-(methyl-11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET). Psychopharmacologia 89, 248–252 (1986). https://doi.org/10.1007/BF00310638
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00310638